Atlas Trials

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Clinical trial NCT03805022 · RECRUITING

Trial details

NCT number
NCT03805022
Sponsor
Institut Bergonié
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Non-metastatic Soft-tissue SarcomaResectable
Start date
2019-02-14
Primary completion
2026-12-01
Enrollment
351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.